Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

Author:

Hortobagyi Gabriel N.1,Stemmer Salomon M.1,Burris Howard A.1,Yap Yoon-Sim1,Sonke Gabe S.1,Paluch-Shimon Shani1,Campone Mario1,Blackwell Kimberly L.1,André Fabrice1,Winer Eric P.1,Janni Wolfgang1,Verma Sunil1,Conte Pierfranco1,Arteaga Carlos L.1,Cameron David A.1,Petrakova Katarina1,Hart Lowell L.1,Villanueva Cristian1,Chan Arlene1,Jakobsen Erik1,Nusch Arnd1,Burdaeva Olga1,Grischke Eva-Maria1,Alba Emilio1,Wist Erik1,Marschner Norbert1,Favret Anne M.1,Yardley Denise1,Bachelot Thomas1,Tseng Ling-Ming1,Blau Sibel1,Xuan Fengjuan1,Souami Farida1,Miller Michelle1,Germa Caroline1,Hirawat Samit1,O’Shaughnessy Joyce1

Affiliation:

1. From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology–Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) — all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) — both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt–Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) — all in Nashville; National Cancer Center...

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3